Literature DB >> 1418867

Antagonism by 8-OH-DPAT, but not ritanserin, of catalepsy induced by SCH 23390 in the rat.

M L Wadenberg1.   

Abstract

In the present experiments, it was shown that the catalepsy induced by the dopamine D1 antagonist SCH 23390 (0.2 mg kg-1 sc), was completely antagonised by the administration of 8-OH-DPAT (0.1 mg kg-1 sc) for the duration of the effect of SCH 23390 (approx. 120 min). Neither the catalepsy induced by raclopride (16 mg kg-1 sc) nor that induced by SCH 23390 (0.2 mg kg-1 sc) could be antagonised by treatment with the 5-HT2 receptor antagonist ritanserin (0.13-2.0 mg kg-1 sc). Administration of SCH 23390 (0.0125-0.2 mg kg-1 sc) produced a significant suppression of avoidance behavior at all doses, and also produced a significant decrease in the number of intertrial crosses. At the higher doses, 0.05 and 0.2 mg kg-1 sc, there were also escape failures. In contrast to the finding in our previous report that raclopride and 8-OH-DPAT in a synergistic manner produce a suppression of conditioned avoidance behavior, no such interaction was found between 8-OH-DPAT (0.1 mg kg-1 sc) and SCH 23390 (6 micrograms kg-1 sc) in the present study.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1418867     DOI: 10.1007/bf01245351

Source DB:  PubMed          Journal:  J Neural Transm Gen Sect


  25 in total

1.  Pharmacodynamic basis for the use of chlorpromazine in psychiatry.

Authors:  S COURVOISIER
Journal:  J Clin Exp Psychopathol       Date:  1956 Jan-Mar

Review 2.  Mechanisms of action of atypical antipsychotic drugs. Implications for novel therapeutic strategies for schizophrenia.

Authors:  A Y Deutch; B Moghaddam; R B Innis; J H Krystal; G K Aghajanian; B S Bunney; D S Charney
Journal:  Schizophr Res       Date:  1991 Mar-Apr       Impact factor: 4.939

3.  Reversal of neuroleptic-induced catalepsy by novel aryl-piperazine anxiolytic drugs.

Authors:  B A McMillen; S M Scott; E A Davanzo
Journal:  J Pharm Pharmacol       Date:  1988-12       Impact factor: 3.765

Review 4.  D1 dopamine receptor--the search for a function: a critical evaluation of the D1/D2 dopamine receptor classification and its functional implications.

Authors:  D Clark; F J White
Journal:  Synapse       Date:  1987       Impact factor: 2.562

5.  Receptor-binding properties in vitro and in vivo of ritanserin: A very potent and long acting serotonin-S2 antagonist.

Authors:  J E Leysen; W Gommeren; P Van Gompel; J Wynants; P F Janssen; P M Laduron
Journal:  Mol Pharmacol       Date:  1985-06       Impact factor: 4.436

6.  Effects of raclopride on exploratory locomotor activity, treadmill locomotion, conditioned avoidance behaviour and catalepsy in rats: behavioural profile comparisons between raclopride, haloperidol and preclamol.

Authors:  V Hillegaart; S Ahlenius
Journal:  Pharmacol Toxicol       Date:  1987-05

7.  SCH 23390, a potential benzazepine antipsychotic with unique interactions on dopaminergic systems.

Authors:  L C Iorio; A Barnett; F H Leitz; V P Houser; C A Korduba
Journal:  J Pharmacol Exp Ther       Date:  1983-08       Impact factor: 4.030

8.  Effects of 5-HT1A agonists and 5-HT2 antagonists on haloperidol-induced dyskinesias in squirrel monkeys: no evidence for reciprocal 5-HT-dopamine interaction.

Authors:  J M Liebman; S C Gerhardt; R Gerber
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

9.  Involvement of extrapyramidal motor mechanisms in the suppression of locomotor activity by antipsychotic drugs: a comparison between the effects produced by pre- and post-synaptic inhibition of dopaminergic neurotransmission.

Authors:  S Ahlenius; V Hillegaart
Journal:  Pharmacol Biochem Behav       Date:  1986-05       Impact factor: 3.533

10.  Suppression of conditioned avoidance by 8-OH-DPAT in the rat.

Authors:  M L Wadenberg; S Ahlenius
Journal:  J Neural Transm       Date:  1988       Impact factor: 3.575

View more
  9 in total

1.  The effects of ziprasidone on regional c-Fos expression in the rat forebrain.

Authors:  C A Jennings; J E Cluderay; J Gartlon; J Cilia; A Lloyd; D N C Jones; E Southam
Journal:  Psychopharmacology (Berl)       Date:  2005-12-03       Impact factor: 4.530

2.  Roles of D1-like dopamine receptors in the nucleus accumbens and dorsolateral striatum in conditioned avoidance responses.

Authors:  Evellyn Claudia Wietzikoski; Suelen Lúcio Boschen; Edmar Miyoshi; Mariza Bortolanza; Lucélia Mendes Dos Santos; Michael Frank; Marcus Lira Brandão; Philip Winn; Claudio Da Cunha
Journal:  Psychopharmacology (Berl)       Date:  2011-07-01       Impact factor: 4.530

Review 3.  Mechanisms of action of atypical antipsychotic drugs: a critical analysis.

Authors:  B J Kinon; J A Lieberman
Journal:  Psychopharmacology (Berl)       Date:  1996-03       Impact factor: 4.530

4.  Antagonism at serotonin 5-HT(2A) receptors modulates functional activity of frontohippocampal circuit.

Authors:  Alessandro Gozzi; Valerio Crestan; Giuliano Turrini; Marcel Clemens; Angelo Bifone
Journal:  Psychopharmacology (Berl)       Date:  2010-01-29       Impact factor: 4.530

5.  Targeted activation of midbrain neurons restores locomotor function in mouse models of parkinsonism.

Authors:  Débora Masini; Ole Kiehn
Journal:  Nat Commun       Date:  2022-01-26       Impact factor: 14.919

6.  Potency mismatch for behavioral and biochemical effects by dopamine receptor antagonists: implications for the mechanism of action of clozapine.

Authors:  M L Wadenberg; S Ahlenius; T H Svensson
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

7.  Differential effect of orexin-1 and CRF-1 antagonism on stress circuits: a fMRI study in the rat with the pharmacological stressor Yohimbine.

Authors:  Alessandro Gozzi; Stefano Lepore; Elena Vicentini; Emilio Merlo-Pich; Angelo Bifone
Journal:  Neuropsychopharmacology       Date:  2013-05-08       Impact factor: 7.853

8.  Ritanserin potentiates the stimulatory effects of raclopride on neuronal activity and dopamine release selectivity in the mesolimbic dopaminergic system.

Authors:  J L Andersson; G G Nomikos; M Marcus; P Hertel; J M Mathé; T H Svensson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-10       Impact factor: 3.000

Review 9.  d-Lysergic Acid Diethylamide (LSD) as a Model of Psychosis: Mechanism of Action and Pharmacology.

Authors:  Danilo De Gregorio; Stefano Comai; Luca Posa; Gabriella Gobbi
Journal:  Int J Mol Sci       Date:  2016-11-23       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.